Examples of using Terminal elimination in English and their translations into Finnish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Terminal elimination half-life was> 20 hours.
The increase in plasma concentrations was strongly correlated with an increase in terminal elimination half-lives.
The terminal elimination half-life(t½) is 10 hours.
Telmisartan is characterised by biexponential decay pharmacokinetics with a terminal elimination half- life of> 20 hours.
The terminal elimination half- life(t1/2) is 5.4 hours.
Amlodipine elimination from plasma is biphasic, with a terminal elimination half-life of approximately 30 to 50 hours.
The terminal elimination half-life of irbesartan is 11-15 hours.
This is due to a decrease in clearance in L-dopa resulting in a prolongation of the terminal elimination half-life(t1/ 2) of levodopa.
Teduglutide has a terminal elimination half-life of approximately 2 hours.
Following inhalation of Brimica Genuair 340/12 micrograms, aclidinium and formoterol showed terminal elimination half-lives of approximately 5 h and 8 h.
The terminal elimination half-life of rilpivirine is approximately 45 hours.
Total plasma clearance of rosiglitazone is around 3 l/h and the terminal elimination half-life of rosiglitazone is approximately 3 to 4 hours.
The terminal elimination half-life of etravirine was approximately 30-40 hours.
Amlodipine elimination from plasma is biphasic, with a terminal elimination half-life of approximately 30 to 50 hours consistent with once daily dosing.
The terminal elimination half-life of raw Dutasteride powder isapproximately 5 weeksat steady state.
The terminal elimination half-life averaged 23.7 hours range 12- 33.
The prolonged persistence andslow elimination of selamectin from plasma is reflected in the terminal elimination half-life values of 8 and 11 days in cats and dogs respectively.
The estimated median terminal elimination half-life of rituximab was 22 days range, 6.1 to 52 days.
Based on the population pharmacokinetic analysis of data in 97 patients with granulomatosis with polyangiitis and microscopic polyangiitis who received 375 mg/m2 MabThera once weekly for four doses,the estimated median terminal elimination half-life was 23 days range, 9 to 49 days.
The mean estimated terminal elimination half-lives of the metabolites MMAV and DMAV are 32 hours and 70 hours, respectively.
The terminal elimination half-life is about 8 hours and steady-state concentrations of tolvaptan are obtained after the first dose.
The plasma elimination is biphasic with the terminal elimination half-life being 22 hours and hence this provides the basic for once daily dosing.
The terminal elimination half-life was prolonged in patients with hepatic impairment compared to healthy controls 4.1-5.0 hours versus 2.8 hours.
Mean plasma terminal elimination half-life of doripenem in healthy young adults is approximately 1 hour and plasma clearance is approximately 15.9 l/hour.
Mean plasma terminal elimination half- life of doripenem in healthy young adults is approximately 1-hour and plasma clearance is approximately 15.9 l/hour.
While the terminal elimination half-life and mean systemic exposure of palonosetron is increased in the subjects with severe hepatic impairment, this does not warrant dose reduction.
The terminal elimination half-life and effective half-life of aclidinium bromide are approximately 14 hours and 10 hours, respectively, following inhalation of twice daily 400 µg doses in COPD patients.